|
|
|
Corporate Sponsor
|
|
|
|
|
|
Dr. Equity Provides His Prognosis on CitiGroup (NYSE:C), Issues
His Price Target
Staff Reporter
Last Updated:- Nov. 24, 2008 - 1:45pm EST
(NEW YORK)-- Dr.
Equity, today's premier online stock professor, issues his research
prognosis and price target for CitiGroup (NYSE: C).
The recent government bailout of Citigroup has reduced systemic
risk of a failure for the institutional bank. Dr, Equity commented, "All indications
show that the government has brought the paddles to CitiGroup's
chest, and shocked the common stock in the chest. Our outlook for
the patient has been upgraded from 'critical' to stable."
Subscribe today to receive Dr. Equity's full detailed price
target, outlook, and technical analysis on the Company.
Dr. Equity's Traders Newsletter. |
|
 Dr.
Equity - Provides Prognosis on Today's Stocks
Become a member
of Dr. Equity's investors monthly newsletter and receive updated trader
alerts, chart
reviews, exclusive interviews and research, and small cap stock
picks.
Mailed each month right to your snail mail address.
Dr. Equity's Monthly Newsletter: $24.95 a month
- Subscribe Today!
|
|
|
|
|
-------------
Contact:
Wall Street Newscast
Email: info@wallstreetnewscast.com
|
|
Disclaimer:
This is NOT a solicitation to Buy or Sell any security, but rather
is for informational purposes only. Content contained herein
includes facts, views, opinions and recommendations of individuals
and organizations deemed of interest. Wall Street Newscast ("WSNC")
does not guarantee the accuracy, completeness or timeliness of, or
otherwise endorse these views, opinions or recommendations, or
give investment advice. WSNC, its affiliates, or directors, may or
may not hold a position in the above security from time to time,
and investors are encourage to consider this as a possible
conflict of interest when reviewing this information. In
Compliance with SEC Rule 17B Wall Street Newscast was NOT
compensated for this research alert.
|
|
